ARCHIVES

In Brief: Former Oklahoma Re. Synar, Opponent of Tobacco, dead at 45 Of Brain Cancer

This article is from The Cancer Letter archive.

Vol. 22 No. 02 | January 12, 1996

Download PDF Visit The Full Archive

Related Articles

Lines Drawn Over HHS Appropriations.

October 5, 2007

NCCN Launches Outcomes Improvement Program

August 12, 2011

In Brief: NCI Will Stop Free Group C distribution Of VP-16 Sept. 1 Unless Bristol Supplies It At No Charge

June 25, 1982

NCAB Approves, NCI Accepts Powers’ Version Of Board’s Organ Systems Recommendations

May 27, 1983

FDA Approves Gleevec For First Line Rx Of CML

January 31, 2003

Aromasin Approved By FDA For ER+ Early Breast Cancer

October 28, 2005